Published online before print May 14, 2009

This Article Full Text Full Text (PDF) All Versions of this Article: ajpath.2009.080831v1 174/6/2254    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by de la Motte, C. Articles by Stern, R. Search for Related Content PubMed PubMed Citation Articles by de la Motte, C. Articles by Stern, R. Related Collections Related Article

(American Journal of Pathology. 2009;174:2254-2264.)
© 2009 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2009.080831

Platelet-Derived Hyaluronidase 2 Cleaves Hyaluronan into Fragments that Trigger Monocyte-Mediated Production of Proinflammatory Cytokines

Carol de la Motte^*, Julie Nigro, Amit Vasanji, Hyunjin Rho^*, Sean Kessler^*, Sudip Bandyopadhyay^*, Silvio Danese, Claudio Fiocchi^* and Robert Stern^¶

From the Departments of Pathobiology,^* and Molecular and Health Technologies, Commonwealth Scientific and Industrial Research Organisation, Victoria, Australia; the Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio; the Division of Gastroenterology, Istituto Clinico Humanitas, Division of Gastroenterology, Milan, Italy; and the Department of Pathology,^¶ Faculty of Medicine, Al Quds University, East Jerusalem, Palestine

Hyaluronan (HA) occurs in the body as a large, hydrating, space-filling, carbohydrate polymer in the extracellular matrix; it has both anti-angiogenic and immunosuppressive properties. Cleavage of HA results in the generation of variably sized fragments that stimulate multiple angiogenic and inflammatory responses in a size-specific manner. In this study, we report that platelets, as well as their megakaryocyte precursors, are unusual among somatic cells in that they contain only hyaluronidase 2 (HYAL2) but not HYAL1. Platelet HYAL2 is sufficient to cleave HA into fragments that are specific for inflammatory and angiogenic signaling; this process occurs in the absence of HYAL1, which is necessary in all other tissues to perform further HA degradation. Platelets can bind to HA, some of which derives from the stressed microvessel endothelial cell surface. Platelet-derived HYAL2 cleaves HA into fragments that stimulate mononuclear leukocytes in the immediate microenvironment to produce proinflammatory cytokines, including interleukin-6 and interleukin-8. Platelets, thus, are not only involved in hemostasis, the earliest step in wound healing, but are also important in the signaling of subsequent inflammatory and angiogenic steps. We hypothesize that aberrations in these sequential steps can promote chronic inflammation, as found in inflammatory bowel disease. The platelet may thus provide an interface between acute and chronic inflammation, wound healing, and their subsequent fibrotic responses.

Related Article

Hyaluronan, Platelets, and Monocytes: A Novel Pro-Inflammatory Triad

Gustavo B. Menezes, Erin F. McAvoy, and Paul Kubes
Am. J. Pathol. 2009 174: 1993-1995. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				G. B. Menezes, E. F. McAvoy, and P. Kubes Hyaluronan, Platelets, and Monocytes: A Novel Pro-Inflammatory Triad Am. J. Pathol., June 1, 2009; 174(6): 1993 - 1995. [Abstract] [Full Text] [PDF]